EVH Financials

Income Statement
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025
Revenue
725.4M
+11.2%
652.5M
+31.5%
496.2M
+5.9%
468.7M
-2.3%
479.5M
Cost of Revenue
636.9M
+11.4%
571.7M
+38.6%
412.5M
+11.0%
371.5M
-2.2%
379.8M
Gross Profit
88.4M
+9.4%
80.8M
-3.5%
83.8M
-13.9%
97.3M
-2.5%
99.8M
Operating Expenses
94.6M
+4.7%
90.4M
-4.2%
94.4M
-81.9%
520.4M
+419.7%
100.1M
R&D
0
0
0
0
0
SG&A
73.1M
+6.2%
68.8M
-5.5%
72.8M
+0.2%
72.7M
-6.4%
77.6M
Operating Income
-6188000
+35.3%
-9561000
+9.8%
-10599000
+97.5%
-423098000
-122893.6%
-344000
EBITDA
16.3M
+24.6%
13.1M
+10.2%
11.9M
-45.2%
21.7M
-17.9%
26.5M
Net Income
-23566000
+16.9%
-28364000
-6.5%
-26632000
+93.8%
-429131000
-1956.8%
-20864000
EPS (Basic)
$-0.21
+16.0%
$-0.25
-4.2%
$-0.24
+93.8%
$-3.85
-1504.2%
$-0.24
EPS (Diluted)
$-0.21
+16.0%
$-0.25
-4.2%
$-0.24
+93.8%
$-3.85
-1504.2%
$-0.24
Shares (Diluted)
113.1M
+0.5%
112.5M
+0.6%
111.9M
+0.3%
111.6M
-2.2%
114.1M
Evolent Health (EVH) — Financials